cerivastatin

(redirected from Lipobay)
Also found in: Dictionary, Thesaurus.
Related to Lipobay: Baycol, cerivastatin

cerivastatin

 [sĕ-riv´ah-stat″in]
an inhibitor of an enzyme involved in the biosynthesis of cholesterol; used as an adjunct in the treatment of hyperlipidemia. Withdrawn in the United States because it is associated with an increased risk for rhabdomyolysis.

cerivastatin

an HMG-CoA reductase inhibitor (Baycol) withdrawn from the market in August 2001 after several cases of fatal rhabdomyolysis.

cerivastatin

Baycol® Cardiology Cholesterol-lowering, HMG-CoA reductase inhibitor/statin for managing hypercholesterolemia and mixed dyslipidemia; it ↑ HDL-C and ↓ LDL-C; withdrawn from the market as it was linked to rhabdomyolysis. See Statin.
References in periodicals archive ?
Lipobay is one of the cheaper types of cholesterol-lowering drugs and GPs are having their arms twisted by the authorities to save costs wherever possible.
A spokeswoman said: "There is a rare but serious reaction when Lipobay is used together with Lopid.
The worldwide complaint is part of an ongoing effort to ensure that all persons around the world who used the potentially deadly drug Lipobay are justly compensated and to assure that those who took the drug are properly informed of its potentially dangerous propensities.
Recent news reports have suggested that over several hundred people have died from their alleged use of Baycol and/or Lipobay worldwide.